Biomedicines | Free Full-Text | IDH Mutations in Glioma: Double-Edged Sword in Clinical Applications?
The role of IDH1 mutation on gene expression in glioblastoma - ScienceDirect
Pathology Outlines - IDH1 (R132H)
Frontiers | Biological Roles and Therapeutic Applications of IDH2 Mutations in Human Cancer
IDH1 mutation in primary GBM: impact on patients' overall survival and... | Download Scientific Diagram
To be Wild or Mutant: Role of Isocitrate Dehydrogenase 1 (IDH1) and 2-Hydroxy Glutarate (2-HG) in Gliomagenesis and Treatment Outcome in Glioma | SpringerLink
Frontiers | Mutant Isocitrate Dehydrogenase Inhibitors as Targeted Cancer Therapeutics
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype | Nature
Isocitrate dehydrogenase | Radiology Reference Article | Radiopaedia.org
Single-nucleus transcriptomics of IDH1- and TP53-mutant glioma stem cells displays diversified commitment on invasive cancer progenitors | Scientific Reports
IDH mutation in glioma: molecular mechanisms and potential therapeutic targets | British Journal of Cancer
Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma: Cancer Cell
Frontiers Publishing Partnerships | Isocitrate Dehydrogenase IDH1 and IDH2 Mutations in Human Cancer: Prognostic Implications for Gliomas
Gene of the month: IDH1 | Journal of Clinical Pathology
Current model of the impact of IDH1 mutation on chromatin remodeling.... | Download Scientific Diagram
Molecular Markers of Gliomas to Predict Treatment and Prognosis: Current State and Future Directions | Exon Publications
IDH1 mutations induce organelle defects via dysregulated phospholipids | Nature Communications
IDH1‑R132H mutation radiosensitizes U87MG glioma cells via epigenetic downregulation of TIGAR
IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response | Science Translational Medicine
Cancers | Free Full-Text | Mutant IDH1 Depletion Downregulates Integrins and Impairs Chondrosarcoma Growth
The implications of IDH mutations for cancer development and therapy | Nature Reviews Clinical Oncology
IVD Antibody Development Services for IDH1 Marker - Creative Biolabs
Mutant IDH is sufficient to initiate enchondromatosis in mice | PNAS
Wild-type and mutated IDH1/2 enzymes and therapy responses | Oncogene
To be Wild or Mutant: Role of Isocitrate Dehydrogenase 1 (IDH1) and 2-Hydroxy Glutarate (2-HG) in Gliomagenesis and Treatment Outcome in Glioma | SpringerLink
Proposed hypothesis of different effects of the IDH1 R132H mutation in... | Download Scientific Diagram
Glioma Classification Markers ATRX, IDH1, and GFAP - Atlas Antibodies
